| Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum S Rafati, A Nakhaee, T Taheri, Y Taslimi, H Darabi, D Eravani, S Sanos, ... Vaccine 23 (28), 3716-3725, 2005 | 172 | 2005 |
| Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis A Mizbani, T Taheri, F Zahedifard, Y Taslimi, H Azizi, K Azadmanesh, ... Vaccine 28 (1), 53-62, 2009 | 126 | 2009 |
| Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies A Bolhassani, T Taheri, Y Taslimi, S Zamanilui, F Zahedifard, N Seyed, ... Experimental parasitology 127 (3), 637-645, 2011 | 108 | 2011 |
| Leishmaniasis and various immunotherapeutic approaches Y Taslimi, F Zahedifard, S Rafati Parasitology 145 (4), 497-507, 2018 | 95 | 2018 |
| Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection D Doroud, F Zahedifard, A Vatanara, AR Najafabadi, Y Taslimi, ... Journal of controlled release 153 (2), 154-162, 2011 | 92 | 2011 |
| Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis A Zadeh-Vakili, T Taheri, Y Taslimi, F Doustdari, AH Salmanian, S Rafati Vaccine 22 (15-16), 1930-1940, 2004 | 81 | 2004 |
| Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, ... PLoS neglected tropical diseases 8 (3), e2751, 2014 | 79 | 2014 |
| Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis N Saljoughian, T Taheri, F Zahedifard, Y Taslimi, F Doustdari, ... PLoS neglected tropical diseases 7 (4), e2174, 2013 | 75 | 2013 |
| Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral … S Rafati, E Gholami, N Hassani, F Ghaemimanesh, Y Taslimi, T Taheri, ... Vaccine 25 (21), 4159-4169, 2007 | 71 | 2007 |
| Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals N Khoshgoo, F Zahedifard, H Azizi, Y Taslimi, MJ Alonso, S Rafati Vaccine 26 (46), 5822-5829, 2008 | 61 | 2008 |
| Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae H Azizi, K Hassani, Y Taslimi, HS Najafabadi, B Papadopoulou, S Rafati Parasitology 136 (7), 723-735, 2009 | 58 | 2009 |
| Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasis S Rafati, N Hassani, Y Taslimi, H Movassagh, A Rochette, ... Clinical and vaccine immunology 13 (10), 1104-1110, 2006 | 58 | 2006 |
| Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites A Badirzadeh, T Taheri, Y Taslimi, Z Abdossamadi, M Heidari-Kharaji, ... PLoS neglected tropical diseases 11 (7), e0005774, 2017 | 57 | 2017 |
| Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate S Dabirian, Y Taslimi, F Zahedifard, E Gholami, F Doustdari, ... PLOS Neglected Tropical Diseases 7 (10), e2491, 2013 | 55 | 2013 |
| Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model A Katebi, E Gholami, T Taheri, F Zahedifard, S Habibzadeh, Y Taslimi, ... Molecular immunology 67 (2), 501-511, 2015 | 52 | 2015 |
| Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis MR Jaafari, M Hatamipour, SH Alavizadeh, A Abbasi, Z Saberi, S Rafati, ... International journal for parasitology: drugs and drug resistance 11, 156-165, 2019 | 46 | 2019 |
| Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against … M Shahbazi, F Zahedifard, T Taheri, Y Taslimi, S Jamshidi, S Shirian, ... PloS one 10 (7), e0132794, 2015 | 44 | 2015 |
| Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patients A Bolhassani, F Zahedifard, Y Taslimi, M Taghikhani, B Nahavandian, ... Indian Journal of Medical Research 130 (5), 533-541, 2009 | 37 | 2009 |
| A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis Y Taslimi, P Sadeghipour, S Habibzadeh, V Mashayekhi, H Mortazavi, ... PLoS Neglected Tropical Diseases 11 (7), e0005750, 2017 | 34 | 2017 |
| Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model M Salehi, T Taheri, E Mohit, F Zahedifard, N Seyed, Y Taslimi, M Sattari, ... Immunotherapy 4 (11), 1107-1120, 2012 | 31 | 2012 |
